SCHEMBL10697548

SCHEMBL10697548

CCNC(=O)CCNC1C=CC=CC1

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.35
FAAH O00519 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10697431 0.84 FPR3 (0.33)
SCHEMBL10696019 0.84 MCL1 (0.31) FAAH
SCHEMBL10698686 0.81 EPHX2 (0.36) EPHX2FAAHALDH1A1HPGDKMT2A
SCHEMBL18727731 0.75
SCHEMBL14295926 0.74
SCHEMBL13741258 0.71 FAAH (0.35) FAAH
SCHEMBL607551 0.68
SCHEMBL10798431 0.68
SCHEMBL1878772 0.68 EPHX2 (0.33) EPHX2
SCHEMBL27817578 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0271023-A2 Use of dihydrophenylamino-acid derivatives and medicines containing them for immunomodulation and cytostasis GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-06-15 EP claimed
EP-0271023-A2 Use of dihydrophenylamino-acid derivatives and medicines containing them for immunomodulation and cytostasis GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-06-15 EP disclosed